科伦药业9月30日获融资买入7278.70万元，融资余额9.08亿元

Core Viewpoint - Kellen Pharmaceutical experienced a 1.05% increase in stock price on September 30, with a trading volume of 703 million yuan, indicating active market interest [1] Financing Summary - On September 30, Kellen Pharmaceutical had a financing buy-in amount of 72.79 million yuan and a financing repayment of 67.17 million yuan, resulting in a net financing buy-in of 5.62 million yuan [1] - As of September 30, the total financing and securities lending balance for Kellen Pharmaceutical was 911 million yuan, with the financing balance at 908 million yuan, accounting for 1.55% of the circulating market value, which is above the 60th percentile level over the past year [1] - The company repaid 28,400 shares in securities lending on September 30, with a sell amount of 121,200 yuan, and the securities lending balance was 2.85 million yuan, below the 50th percentile level over the past year [1] Business Performance - As of June 30, Kellen Pharmaceutical had 34,200 shareholders, an increase of 2.55% from the previous period, with an average of 38,138 circulating shares per shareholder, a decrease of 2.49% [2] - For the first half of 2025, Kellen Pharmaceutical reported a revenue of 9.083 billion yuan, a year-on-year decrease of 23.20%, and a net profit attributable to shareholders of 1.001 billion yuan, down 44.41% year-on-year [2] - Since its A-share listing, Kellen Pharmaceutical has distributed a total of 6.697 billion yuan in dividends, with 3.386 billion yuan distributed over the past three years [2] Institutional Holdings - As of June 30, 2025, the top ten circulating shareholders of Kellen Pharmaceutical included notable funds such as China Europe Medical Health Mixed A, which increased its holdings by 12.69 million shares to 42.60 million shares [3] - Hong Kong Central Clearing Limited, the fourth-largest shareholder, reduced its holdings by 2.71 million shares to 39.99 million shares [3] - Other significant shareholders included ICBC Frontier Medical Stock A and GF Multi-Factor Mixed, with varying changes in their holdings [3]